Rocket Pharmaceuticals (RCKT) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Q3 2025 value amounting to $14.6 million.
- Rocket Pharmaceuticals' Other Gross PP&E Adjustments rose 4171.26% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 4171.26%. This contributed to the annual value of $8.4 million for FY2024, which is 14225.22% up from last year.
- According to the latest figures from Q3 2025, Rocket Pharmaceuticals' Other Gross PP&E Adjustments is $14.6 million, which was up 4171.26% from $6.4 million recorded in Q2 2025.
- In the past 5 years, Rocket Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $37.8 million during Q1 2023, and its lowest value of -$32.5 million during Q4 2021.
- In the last 5 years, Rocket Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$3.2 million in 2023 and averaged -$6.1 million.
- Examining YoY changes over the last 5 years, Rocket Pharmaceuticals' Other Gross PP&E Adjustments showed a top increase of 1315000.0% in 2024 and a maximum decrease of 8914.67% in 2024.
- Rocket Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$32.5 million in 2021, then grew by 12.82% to -$28.3 million in 2022, then surged by 30.1% to -$19.8 million in 2023, then soared by 142.25% to $8.4 million in 2024, then soared by 74.96% to $14.6 million in 2025.
- Its Other Gross PP&E Adjustments stands at $14.6 million for Q3 2025, versus $6.4 million for Q2 2025 and $7.7 million for Q1 2025.